We therefore concluded that CPT1a and KAT2a may act in concert in patients with breast cancer to promote metastatic growth specifically in organs those interstitial nutrient composition is palmitate enriched, with the latter being an oleate-enriched organ95. The gene discussed is CPT1A; the disease is breast cancer.